abagovomab 19
abciximab 20
abituzumab 19
abrilumab 16
actoxumab 9
adalimumab 16
aducanumab 7
afasevikumab 13
alacizumab_pegol 10
alemtuzumab 20
alirocumab 14
amatuximab 28
andecaliximab 17
anifrolumab 17
anrukinzumab 16
aprutumab 9
aprutumab_ixadotin 9
arcitumomab 13
ascrinvacumab 4
atezolizumab 15
atinumab 12
avelumab 11
basiliximab 18
bavituximab 24
begelomab 15
benralizumab 20
bevacizumab_beta 16
bezlotoxumab 9
bimagrumab 10
bleselumab 12
blinatumomab 23
blosozumab 26
bococizumab 14
brazikumab 10
brentuximab_vedotin 21
briakinumab 14
brodalumab 5
brolucizumab 22
brontictuzumab 18
burosumab 15
cabiralizumab 22
camrelizumab 10
canakinumab 20
cantuzumab_ravtansin 33
carlumab 12
carotuximab 19
cergutuzumab_amunaleukin2 22
cergutuzumab_amunaleukin 22
certolizumab_pegol 24
cetiximab 33
citatuzumab_bogatox 23
cixutumumab 16
clivatuzumab_tetraxetan 13
codrituzumab 27
conatumumab 6
concizumab 27
crenezumab 17
crizanlizumab 21
crotedumab 18
dacetuzumab 19
daclizumab 10
dalotuzumab 23
dapirolizumab_pegol 22
daratumumab 12
dectrekumab 8
demcizumab 19
denosumab 8
depatuxizumab 17
depatuxizumab_mafodotin 17
dezamizumab 13
dinutuximab 27
diridavumab 11
domagrozumab 13
drozitumab 9
duligotuzumab 16
durvalumab 4
dusigitumab 6
efalizumab 27
efungumab 23
eldelumab 10
elezanumab 14
elgemtumab 8
elotuzumab 10
emactuzumab 14
emapalumab 23
emibetuzumab 11
enavatuzumab 23
enfortumab_vedotin 10
enoblituzumab 14
enokizumab 19
enoticumab 12
ensituximab 18
eptinezumab 14
erenumab 12
etaracizumab 14
etrolizumab 21
evinacumab 20
evolocumab 6
farletuzumab 3
fasinumab 16
fezakinumab 11
fibatuzumab 5
ficlatuzumab 12
firivumab 24
flanvotumab 8
fletikumab 13
foralumab 8
foravirumab 12
fremanezumab 23
fresolimumab 16
fulranumab 18
futuximab 13
galcanezumab 14
ganitumab 19
gantenerumab 9
gemetuzumab 20
gemtuzumab2 23
gemtuzumab 18
gevokizumab 19
girentuximab 22
glembatumumab 14
glembatumumab_vedotin 14
guselkumab 17
ibalizumab 21
ibritumomab 20
icrucumab 5
idarucizumab 24
ifabotuzumab 5
imalumab 14
imgatuzumab 13
inclacumab 10
indatuximab_ravtansin 20
indusatumab 9
inebilizumab 21
intetumumab 7
iodine_girentuximab 26
ipilimumab 3
iratumumab 6
isatuximab 24
itolizumab 16
ixekizumab 28
labetuzumab_govitecan 15
lambrolizumab 19
lampalizumab 18
lanadelumab 16
landogrozumab 13
laprituximab 19
lebrikizumab 31
lendalizumab 21
lenzilumab 11
lifastuzumab_vedotin 20
ligelizumab 19
lilotomab 29
lirilumab 12
lodelcizumab 15
lokivetmab 22
lorvotuzumab_mertansin 16
lucatumumab 26
lumretuzumab 10
lupartumab 7
lutikizumab 16
margetuximab 23
milatuzumab 28
mirvetuximab 20
mirvetuximab_soravtansin 20
modotuximab 24
mogamulizumab 24
monalizumab 16
motavizumab 21
moxetumomab_pasudotox 19
namilumab 11
naratuximab 21
naratuximab_emtansin 21
narnatumab 12
navicixizumab2 21
navicixizumab 21
navivumab 29
necitumumab 8
nemolizumab 19
nesvacumab 12
nivolumab 7
obiltoxaximab 15
obinutuzumab 28
ocaratuzumab 18
ofatumumab 13
olaratumab 16
olokizumab 23
omalizumab 19
onartuzumab 17
ontuxizumab 18
opicinumab 11
orticumab 9
otelixizumab 29
oxelumab 10
ozanezumab 24
pamrevlumab 9
panobacumab 16
parsatuzumab 21
pasotuxizumab 19
pateclizumab 14
patritumab 14
pembrolizumab 19
perakizumab 15
pidilizumab 13
pinatuzumab_vedotin 15
plozalizumab 24
pogalizumab 20
polatuzumab_vedotin 19
ponezumab 25
prezalumab 11
pritoxaximab 18
quilizumab 18
racotumomab 20
radretumab 13
ralpancizumab 19
ramucirumab 12
ranevetmab 16
ranibizumab 18
refanezumab 19
remtolumab 15
rilotumumab 10
rinucumab 14
risankizumab 29
rituximab 16
rivabazumab 11
robatumumab 20
roledumab 19
romosozumab 16
rontalizumab 19
rosmantuzumab 18
rozanolixizumab 17
sacituzumab 13
sacituzumab_govitecan 13
samalizumab 22
sapelizumab 22
sarilumab 11
secukinumab 8
seribantumab 12
setoxaximab 33
sifalimumab 5
siltuximab 16
simtuzumab 23
sirukumab 9
solanezumab 22
solitomab 15
stamulumab 14
suptavumab 15
suvizumab 14
tabalumab 5
tadocizumab 11
tamtuvetmab 25
tanezumab 19
tarextumab 7
tavolixizumab 12
telisotuzumab 23
teplizumab 15
tesidolumab 15
tezepelumab 20
tigatuzumab 14
tildrakizumab 18
timolumab 12
tisotumab 8
tosatoxumab 22
tositumomab 20
tralokinumab 19
trastuzumab 19
tregalizumab 21
trevogrumab 8
ublituximab 25
urelumab 12
ustekinumab 21
utomilumab 23
vadastuximab 17
vadastuximab_talirin 17
vandortuzumab_vedotin 10
vantictumab 15
vanucizumab2 16
vanucizumab 21
varlilumab 12
vatelizumab 15
vedolizumab 17
veltuzumab 10
vesencumab 10
vorsetuzumab 17
vorsetuzumab_mafodotin 17
vunakizumab 25
xentuzumab 14
zatuximab 24
